HA
AGN

Harfst & Associates’s Allergan plc AGN Stock Holding History

Harfst & Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-16
Closed -$5K – 266
2015
Q4 		$5K Hold
16
– – ﹤0.01% 264
2015
Q3 		$4K Hold
16
– – ﹤0.01% 256
2015
Q2 		$5K Buy
+16
New +$4.77K ﹤0.01% 300

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Harfst & Associates's AGN Position: Q1 2016 in Review

Harfst & Associates sold out of Allergan plc (AGN) in Q1 2016, closing a stake of 16 shares — an estimated $5K sold.

Harfst & Associates first reported a position in AGN in Q2 2015 and held it in 3 quarters. The position peaked at $5K in Q4 2015. 1,119 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

  • Harfst & Associates reported no remaining Allergan plc position as of Q1 2016 after selling out during the quarter.
  • Harfst & Associates sold 16 Allergan plc shares in Q1 2016, an estimated $5K.
  • Harfst & Associates first reported a position in Allergan plc in Q2 2015 and held it in 3 quarters.
  • Harfst & Associates's Allergan plc position peaked at $5K in Q4 2015.
  • 1,119 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on Harfst & Associates's 13F filing for Q1 2016, filed 3 May 2016.